Yanni & Associates Investment Advisors Q2 2026 Portfolio Changes

As of June 30th, 2026, Yanni & Associates Investment Advisors has managed its portfolio with a total value of $108.4 million.

Purchase Activity

In this quarter, the firm demonstrated active buying in several exchange-traded funds (ETFs). The most significant purchase was SCHX, which saw an increase of 689,375 shares or approximately 0.16% weight from its previous position.

• SCHX gained substantial share count (689k increase), though its portfolio allocation percentage remained stable at 11.77%. This ETF, known as Schwab Strategic Trust I, is a widely held institutional wrapper.
• SCHJ, another Schwab Institutional Equity Fund, increased its share count by 145,726 shares (adding approximately +0.39% weight). Its portfolio allocation percentage rose to 3.32%, indicating a strategic addition.
• FNDX added more than just new investors; it gained significant holdings with an increase of over $1 million in value, though its share count decreased slightly by 0.14%. This Schwab Fundamental Equity Fund now represents a key part of the portfolio.
• The firm also purchased shares in IWF, adding approximately $73k worth to its position. This iShares Core Small-Cap ETF saw a massive increase in share count (+248%) and allocation percentage (now 1.17%).
• Additionally, there was buying activity in FTSL ($359k added), ONEQ ($602k added), SCHX again mentioned but already covered, IVW, IVE, SPY, and IVV.

Sales/Reduction Activity

Conversely, the firm reduced its positions in several ETFs during Q2:

• SPY, despite being a core holding worth $18.5 million (17.03% allocation), saw a slight reduction of 0.16% weight and lost 388 shares.
• IVV experienced a small decrease in portfolio percentage (down by -0.61%) due to share reduction (-110 shares).
• IVW, an iShares Core Small-Cap ETF, saw its portfolio percentage decrease slightly by -0.91%.
• IVE's allocation decreased by 1.56%, reflecting share reduction (-398 shares).
• The firm also sold out of BMY, completely exiting the position in Bristol Myers Squibb stock (allocation: 0.57%). This was a significant sale.
• Other ETFs like IJR and SCHG saw minor reductions or decreases in allocation percentages (-1.81% and -0.96%, respectively).

The overall portfolio shows active management, with changes occurring across various holdings. The firm's decisions reflect a dynamic approach to asset allocation.